First and most importantly, the promiscuity of CXCR7 ligands and the widespread expression of CXCR4 and CXCR3 in tumor tissues [6] makes the dissection of CXCR7-specific signaling particularly challenging. This evidence concerns the gene CXCR4 and neoplasm.